Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 200 μg/50 mL and 400 μg/100 mL Single Dose flexible containers (Bags).
source https://www.pharmatutor.org/pharma-news/2020/aurobindo-pharma-receives-usfda-approval-for-dexmedetomidine-hcl-in-sodium-chloride-injection
No comments:
Post a Comment